SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000109657-10-000035
Filing Date
2010-11-12
Accepted
2010-11-12 12:44:49
Documents
7
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 OXIS FORM 10-Q 9-30-2010 quarterlyreport.htm 10-Q 560071
2 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex311.htm EX-31.1 13736
3 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex312.htm EX-31.2 14241
4 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex321.htm EX-32.1 6263
5 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex322.htm EX-32.2 6150
6 CERTIFICATE OF DESIGNATION OF SERIES I PREFERRED STOCK ex41.htm EX-4.1 68111
7 SERIES I PREFERRED STOCK PURCHASE AGREEMENT, DATED AS OF NOVEMBER 8, 2010, BY AN ex101.htm EX-10.1 90855
  Complete submission text file 0000109657-10-000035.txt   761139
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 101184853
SIC: 2834 Pharmaceutical Preparations